National Center for Child Health and Development, Tokyo, Japan.
National Center for Global Health and Medicine/National College of Nursing, Tokyo, Japan.
J Diabetes Investig. 2020 Sep;11(5):1318-1325. doi: 10.1111/jdi.13238. Epub 2020 Mar 25.
AIMS/INTRODUCTION: We aimed to evaluate the metabolic status of pregnant women by assessing metabolic biomarkers of participants in the Japan Environment and Children's Study, a nationwide, multicenter, pregnancy and birth cohort.
Pregnant women aged 14-50 years were studied in 15 centers across Japan. Clinical information was obtained using self-administered questionnaires. Blood samples were taken during the first two trimesters to measure metabolic biomarkers. Samples were divided into seven groups according to the weeks of pregnancy.
Among 82,972 pregnant women, 43 had only type 1 diabetes, 78 had only type 2 diabetes, 2,315 had only gestational diabetes and 354 had only dyslipidemia. Glycated hemoglobin, total cholesterol, low-density lipoprotein cholesterol and triglyceride across all the percentiles increased as prepregnancy body mass index increased, whereas high-density lipoprotein cholesterol levels across all the percentiles decreased as body mass index increased. Glycated hemoglobin was high in participants with type 1 diabetes or type 2 diabetes only, but not in those with gestational diabetes or hyperlipidemia only. Participants with type 2 diabetes or dyslipidemia only had high triglyceride in the first trimester, which then decreased in the second trimester. Participants with type 2 diabetes only also showed low high-density lipoprotein cholesterol, whereas participants with dyslipidemia only showed high total cholesterol and low-density lipoprotein cholesterol throughout.
Metabolic biomarkers were affected by blood sample timing and underlying metabolic disease. The Japan Environment and Children's Study will clarify the influences of metabolic status during pregnancy on the health and development of the offspring in future studies.
目的/引言:我们旨在通过评估日本环境与儿童研究参与者的代谢生物标志物来评估孕妇的代谢状况,该研究是一项全国性的多中心妊娠和出生队列研究。
在日本的 15 个中心研究了年龄在 14-50 岁的孕妇。使用自我管理的问卷获得临床信息。在头两个三个月采集血样以测量代谢生物标志物。根据妊娠周数将样本分为七组。
在 82972 名孕妇中,有 43 名仅有 1 型糖尿病,78 名仅有 2 型糖尿病,2315 名仅有妊娠期糖尿病,354 名仅有血脂异常。所有百分位的糖化血红蛋白、总胆固醇、低密度脂蛋白胆固醇和甘油三酯均随孕前体重指数的增加而升高,而所有百分位的高密度脂蛋白胆固醇水平随体重指数的增加而降低。仅 1 型糖尿病或 2 型糖尿病患者的糖化血红蛋白升高,但仅患有妊娠期糖尿病或血脂异常的患者则没有。仅患有 2 型糖尿病或血脂异常的患者在孕早期甘油三酯较高,然后在孕中期降低。仅患有 2 型糖尿病的患者还表现出低高密度脂蛋白胆固醇,而仅患有血脂异常的患者整个孕期总胆固醇和低密度脂蛋白胆固醇均升高。
代谢生物标志物受血样采集时间和潜在代谢疾病的影响。日本环境与儿童研究将在未来的研究中阐明妊娠期间代谢状况对后代健康和发育的影响。